Riya Khetan

Dr Riya Khetan

School of Pharmacy and Biomedical Science

College of Health


Year Citation
2025 Khetan, R., Lokman, N. A., Eldi, P., Price, Z. K., Oehler, M. K., Brooks, D. A., . . . Albrecht, H. (2025). Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer. International Journal of Molecular Sciences, 26(17), 8529.
DOI
2025 Muta, T., Khetan, R., Song, Y., & Garg, S. (2025). Optimising Cannabidiol Delivery: Improving Water Solubility and Permeability Through Phospholipid Complexation. International Journal of Molecular Sciences, 26(6), 28 pages.
DOI Scopus4 WoS4 Europe PMC3
2024 Saddam Hussain, M., Khetan, R., Albrecht, H., Krasowska, M., & Blencowe, A. (2024). Oligoelectrolyte-mediated, pH-triggered release of hydrophobic drugs from non-responsive micelles: Influence of oligo(2-vinyl pyridine)-loading on drug-loading, release and cytotoxicity. International Journal of Pharmaceutics, 661(124368), 15 pages.
DOI Scopus5 WoS3 Europe PMC1
2024 Abid, F., Virgo, E., Kennewell, T. L., Khetan, R., Haidari, H., Kopecki, Z., . . . Garg, S. (2024). The Acid-Buffered Engineered Gel Promotes In Vitro Cutaneous Healing and Fights Resistant Bacteria in Wounds. Pharmaceutics, 16(11), 15 pages.
DOI Scopus1 WoS1
2024 Rajapaksha, W., Khetan, R., Johnson, I. R. D., Blencowe, A., Garg, S., Albrecht, H., & Gillam, T. A. (2024). Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment. Frontiers in Drug Delivery, 4(1339936), 19 pages.
DOI Scopus10 WoS7 Europe PMC2
2024 Khetan, R., Eldi, P., Lokman, N. A., Ricciardelli, C., Oehler, M. K., Blencowe, A., . . . Albrecht, H. (2024). Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation.. J Ovarian Res, 17(1), 156.
DOI Scopus2 WoS2 Europe PMC2
2023 Youssef, S. H., Kim, S., Khetan, R., Afinjuomo, F., Song, Y., & Garg, S. (2023). The development of 5-fluorouracil biodegradable implants: A comparative study of PCL/PLGA blends. Journal of Drug Delivery Science and Technology, 81(104300), 14 pages.
DOI Scopus14 WoS13
2023 Saddam Hussain, M., Khetan, R., Clulow, A. J., Ganesan, R., MacMillan, A., Robinson, N., . . . Blencowe, A. (2023). Teaching an Old Dog New Tricks: A Global Approach to Enhancing the Cytotoxicity of Drug-Loaded, Non-responsive Micelles Using Oligoelectrolytes. ACS Applied Materials and Interfaces, 16(8), 9736-9748.
DOI Scopus4 WoS4 Europe PMC2
2022 Khetan, R., Dharmayanti, C., Gillam, T. A., Kübler, E., Klingler-Hoffmann, M., Ricciardelli, C., . . . Albrecht, H. (2022). Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers, 14(10), 1-32.
DOI Scopus12 WoS12 Europe PMC11

Courses I teach

  • BIOL 1050 Human Physiology 101 (2025)
  • CHEM 1007 Chemistry 101 (2025)
  • PHAR 2009 Drug Development 1 (2025)
  • PHAR 2010 Drug Discovery (2025)
  • CHEM 1006 Chemistry 100 (2024)
  • CHEM 1007 Chemistry 101 (2024)
  • PHAR 2009 Drug Development 1 (2024)

Connect With Me

External Profiles

Other Links